ATL-001 (Ciclopirox oral solution)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for ATL-001 (Ciclopirox oral solution), covering 2026-03-24 to 2026-03-24. Get the full timeline:
Most recent: Clinical Trial Update: A Study to Investigate the Improvement of Photosensitivity in Terms of Skin Lesions Associated With CEP Following Administration of Oral ATL-001 (Ciclopirox Oral Solution) in Participants Aged >18 Years of Age With CEP [Phase 1, Phase 2]